Company Overview and News

 
[Press] Oil Field Chemicals Market Foraying into Emerging Economies 2016 - 2024

2017-10-28 oilvoice
Global Oil Field Chemicals Market: Overview Oil field chemicals are used for exploration of natural resources and at various stages during the production of the gas and oil as corrosion inhibitors, drilling additives, demulsifiers and paraffin dispersants, cementing super plasticizers, and repair system for cementing failures. As the dependency on the oil and gas industry continues, and an increasing number of exploration activities across the world, the demand in the global oil field chemicals market is escalating and is expected to expand at a healthy CAGR during the forecast period of 2016 to 2024.
Upvote Downvote

 
Organic Friction Modifier Additives Market is Estimated to Reach US$ 500 Mn by 2022 - Future Market Insights

2017-10-05 prnewswire
Organic Friction Modifier Additives Market: Manufacturers are Emphasising on Capacity Expansion & Further Enhancement of Product Efficacy
Upvote Downvote

2
Bromine - Global Market Outlook (2017-2023)

2017-10-03 prnewswire
NEW YORK, Oct. 3, 2017 /PRNewswire/ -- According to Stratistics MRC, the Global Bromine Market is expected to grow from $2.35 billion in 2016 to reach $4.28 billion by 2023 with a CAGR of 8.9%. Read the full report: https://www.reportlinker.com/p05126481 Increasing consumption of bromine in various end use industries such as oil & gas, automotive, pharmaceuticals, textile, agricultural, and electronics will be one of the major factors that will have a positive impact on the growth of the market.
Upvote Downvote

 
Antioxidants: Applications and Global Markets

2017-09-25 prnewswire
LONDON, Sept. 25, 2017 /PRNewswire/ -- The global market for antioxidants should reach $6.4 billion by 2022 from $5.2 billion in 2017 at a compound annual growth rate (CAGR) of 4.2%, from 2017 to 2022. Download the full report: https://www.reportbuyer.com/product/2837391 • The rubber and latex application market for antioxidants is expected to grow from $2.2 billion in 2017 to nearly $2.7 billion in 2022 at a CAGR of 3.
Upvote Downvote

 
Bromine Market by Derivative, Application, and Region - Global Forecast to 2022

2017-08-14 prnewswire
Growing use of bromine in mercury mitigation, in flame retardants and other diverse applications is driving the global bromine market The global bromine market was USD 2.47 billion in 2016 and is projected to reach USD 3.96 billion by 2022, at a CAGR of 8.4% between 2017 and 2022. The market is witnessing growth due to the increasing consumption of bromine in mercury mitigation in coal fired power plants and escalating demand for flame retardants due to strict fire safety regulations.
Upvote Downvote

1
Bromine Market Worth 3.96 Billion USD by 2022

2017-08-03 prnewswire
The report "Bromine Market by Derivative (Organobromines, Clear Brine Fluids, Hydrogen Bromide), Application (Flame Retardants, Water Treatment, HBr Flow Batteries, Mercury Emission Control, PTA Synthesis), and Region - Global Forecast to 2022", the global market was USD 2.47 Billion in 2016 and is projected to reach USD 3.96 Billion by 2022, at a CAGR of 8.4% between 2017 and 2022.
Upvote Downvote

 
Warren Buffett’s General Reinsurance buys stake in Lanxess

2017-05-29 livemint
Shares of Lanxess rose as much as 6.8%, erasing an earlier decline, after General Reinsurance’s 3% stake was unveiled
Upvote Downvote

 
Liberty Sirius XM Group (LSXMK) Lead 12 Activist Investor Reports

2017-04-25 investorplace
When a person or group of persons acquires beneficial ownership of more than 5% of a company’s equity securities, they are required to file a Schedule 13D or 13G with the SEC.
Upvote Downvote

 
Activist Investor Report – 28 Filings to Watch

2017-04-10 investorplace
There were 28 notable investor filings in the last day. QVC owner Liberty Interactive (NASDAQ:LVNTA) and Avis Budget Group, Inc. (NASDAQ:CAR) are two large companies of interest in the activist investor filings.
Upvote Downvote

 
Factors that Could Dampen Chemical Industry Momentum

2017-04-01 zacks
The chemical industry is gradually gaining strength on continued momentum across major end-markets. While chemical makers are poised to gain from strength across automotive and construction sectors, strategic growth measures and investment on capacity expansion, the industry is still reeling under many challenges. There are a few reasons to be watchful about the chemical industry in the near term, which we have outlined below:
Upvote Downvote

 
Chemtura Increases Prices for Petroleum Additives Products

2017-03-25 indiainfoline
Chemtura Corporation (NYSE: CHMT) (EURONEXT: CHMT) has announced today that effective April 1, 2017 or as contracts allow, as a result of the continued escalation of costs it will increase prices globally for the following Petroleum Additives products. This is necessary to sustain Chemtura’s ability to provide high quality products, service levels and innovative offerings. Chemtura representatives will be in contact with customers to provide more specific information.
Upvote Downvote

 
Flame Retardant Market Analysis By Product (Halogenated (Brominated, Antimony Trioxide), Non Halogenated (Aluminum Hydroxide, Magnesium Dihydroxide, Phosphorous)), By Application, By End-Use And Segment Forecasts, 2014 - 2025

2017-03-20 prnewswire
LONDON, March 20, 2017 /PRNewswire/ -- The global flame retardants market is expected to reach USD 11.96 billion by 2025, according to a new report by Grand View Research, Inc. Favorable regulatory scenario promoting the use of these materials for fire safety is expected to fuel market growth over the forecast period. Flame retardants are added to potentially flammable products as a precautionary measure against fire hazards.
Upvote Downvote

 
New Board Members Appointed at Rackspace

2017-02-27 marketwired
SAN ANTONIO, TX--(Marketwired - February 27, 2017) - Rackspace® today announced newly appointed members of its board of directors, which features respected leaders from many of the world's top technology and financial services companies. The new board members will help Rackspace advance its mission of delivering specialized expertise and Fanatical Support® for the world's leading clouds, including Amazon Web Services® (AWS), Microsoft® Azure®, OpenStack® and VMware®, along with dedicated servers.
Upvote Downvote

 
Technical Roundup on Specialty Chemicals Stocks -- PolyOne, Valspar, Chemtura, and Ferro

2017-02-14 prnewswire
For today, Stock-Callers.com draws attention to PolyOne Corp. (NYSE: POL), The Valspar Corp. (NYSE: VAL), Chemtura Corp. (NYSE: CHMT), and Ferro Corp. (NYSE: FOE). According to a report by the American Chemistry Council, the US Specialty Chemicals markets ended fourth quarter 2016 on a good note, with volumes rising 0.3% in December, following an upwardly revised 0.5% gain in November. Sign up today and download for free the research reports for the stocks covered today at:
Upvote Downvote

 
Is Chemtura Corporation a Great Stock for Value Investors?

2017-01-23 zacks
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process.
Upvote Downvote

Related Articles

GNCA: Genocea Biosciences Analysis and Research Report

2018-04-25 - Asif

Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...

AMZN: Amazon.com, Inc Analysis and Research Report

2018-04-25 - Asif

Overview Amazon.com opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...